Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

Seymour, Leonard W; Ferry, David R; Kerr, David J; Rea, Daniel; Whitlock, Maggie; Poyner, Richard; Boivin, Christopher; Hesslewood, Stuart; Twelves, Christopher; Blackie, Robert; Schatzlein, Andreas; Jodrell, Duncan; Bissett, Donald; Calvert, Hilary; Lind, Mike; Robbins, Adele; Burtles, Sally; Duncan, Ruth; Cassidy, James.
Int J Oncol; 34(6): 1629-36, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19424581